Goodwin Advises DualityBio on Global Collaboration and License Agreement With Genentech
September 09, 2026
September 09, 2026
BOSTON, Massachusetts, Sept. 9 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises DualityBio on Global Collaboration and License Agreement With Genentech
*
The Life Sciences team advised DualityBio on a collaboration and license agreement with Genentech, a member of the Roche Group, to develop next-generation antibody-drug conjugates (ADCs) built on the company's proprietary DualityBio . . .
* * *
Goodwin Advises DualityBio on Global Collaboration and License Agreement With Genentech
*
The Life Sciences team advised DualityBio on a collaboration and license agreement with Genentech, a member of the Roche Group, to develop next-generation antibody-drug conjugates (ADCs) built on the company's proprietary DualityBio . . .